Published in Women's Health Weekly, January 20th, 2005
This trial will consist of a pharmacokinetic study in normal, healthy volunteers. The objectives of the clinical study are to determine the safety and tolerability of the DURIN leuprolide implant, as well as evaluate the pharmacokinetic profile of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly